Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Zuellig Pharma, officially known as Zuellig Pharma Holdings Pte Ltd, is a leading provider of research and development services within the healthcare sector. Headquartered in Singapore, the company operates extensively across Asia, serving key markets in the region. Since its founding in 1915, Zuellig Pharma has established a strong reputation for delivering innovative solutions in pharmaceutical distribution, clinical research, and healthcare logistics.
Specialising in research and development services, Zuellig Pharma focuses on advancing healthcare through customised solutions that support pharmaceutical innovation and patient care. Its extensive network and expertise position it as a notable player in the industry, recognised for its commitment to quality and operational excellence. With a history of strategic growth and a focus on technological advancement, Zuellig Pharma continues to shape the future of healthcare services in Asia.
51
DitchCarbon score
+18 vs industry average
Zuellig Pharma’s score of 51 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Zuellig Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Research Services has below-average carbon intensity
Industry performance
0.198
20182025
The Research Services industry has reduced its overall emissions by 19% since 2018
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Zuellig Pharma's reported carbon emissions
Zuellig Pharma, headquartered in Singapore and operating in Research and development services, reported total market-based carbon emissions of approximately 232.3 million kg CO2e in 2024. This includes about 14.7 million kg CO2e from Scope 1, approximately 22.2 million kg CO2e from Scope 2 (market-based), and roughly 165.4 million kg CO2e from Scope 3 emissions. Key Scope 3 contributors in 2024 were purchased goods and services (approximately 79.3 million kg CO2e) and upstream transportation and distribution (around 68.0 million kg CO2e).
Looking back, their total market-based emissions were approximately 296.5 million kg CO2e in 2023, 287.1 million kg CO2e in 2022, 430.1 million kg CO2e in 2021, and 402.5 million kg CO2e in 2020. In 2019, their total reported emissions were about 49.4 million kg CO2e, with Scope 1 data not available for that year.
Zuellig Pharma has committed to several ambitious reduction targets. The company aims to reduce absolute Scope 1 and 2 GHG emissions by 42% by 2030, using 2021 as a baseline year. Additionally, they commit to reducing absolute Scope 3 GHG emissions from fuel and energy-related activities, upstream transportation and distribution, and waste generated in operations by 25% within the same timeframe (2021-2030). These climate commitments are cascaded from Zuellig Pharma Holdings, the source organization for their CDP reporting and performance data. The company also aligns with the national target of reaching carbon neutrality by 2050 for Scope 1 and 2 emissions, as observed in a document from 2024, aligning with Hong Kong's targets.
Assessing Zuellig Pharma as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Zuellig Pharma and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Zuellig Pharma’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Zuellig Pharma2 months ago
51
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more